AK-1830

N/A

Report date: 2024/04/25 14:31:57
NME

Base Information

Drug NameAK-1830
Drug Alias NameAK-1830ARRY-954
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A inhibitors
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArray Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Pharma America Corp
Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A